KD

Kummari Dhanunjaya

Active Director Director DIN 11551836
DIN 11551836 First appointment Feb 2026 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Kummari Dhanunjaya

Data last updated:

Kummari Dhanunjaya is a Director at Whitekart Technologies Private Limited (since 2026) and Director at Vetxen Pharma Private Limited (since 2026). The companies operate in Healthcare.

DIN 11551836
Primary Designation Director
Industry Healthcare
First Appointment 17 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Feb 20262026Active
Vetxen Pharma Private Limited U21006TS2026PTC211543
Director17 Feb 20262026Active

Board colleagues of Kummari Dhanunjaya

Directorship timeline

Open interactive timeline →
Vetxen Pharma Private Limited
Whitekart Technologies Private Limited
Premium access

Shareholding and investment profile for Kummari Dhanunjaya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kummari Dhanunjaya

Kummari Dhanunjaya currently holds 2 directorships: Whitekart Technologies Private Limited (Director, since 25 Feb 2026); Vetxen Pharma Private Limited (Director, since 17 Feb 2026).

Kummari Dhanunjaya was first appointed on 17 Feb 2026 as Director at Vetxen Pharma Private Limited.

The current boards of Kummari Dhanunjaya's companies include Poreddy Sambasiva Reddy (Whitekart Technologies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available